(Press-News.org) JACKSONVILLE, Fla. -- Cancer researchers dream of the day they can force tumor cells to morph back to the normal cells they once were. Now, researchers on Mayo Clinic's Florida campus have discovered a way to potentially reprogram cancer cells back to normalcy.
The finding, published in Nature Cell Biology, represents "an unexpected new biology that provides the code, the software for turning off cancer," says the study's senior investigator, Panos Anastasiadis, Ph.D., chair of the Department of Cancer Biology on Mayo Clinic's Florida campus.
That code was unraveled by the discovery that adhesion proteins -- the glue that keeps cells together -- interact with the microprocessor, a key player in the production of molecules called microRNAs (miRNAs). The miRNAs orchestrate whole cellular programs by simultaneously regulating expression of a group of genes. The investigators found that when normal cells come in contact with each other, a specific subset of miRNAs suppresses genes that promote cell growth. However, when adhesion is disrupted in cancer cells, these miRNAs are misregulated and cells grow out of control. The investigators showed, in laboratory experiments, that restoring the normal miRNA levels in cancer cells can reverse that aberrant cell growth.
"The study brings together two so-far unrelated research fields -- cell-to-cell adhesion and miRNA biology -- to resolve a long-standing problem about the role of adhesion proteins in cell behavior that was baffling scientists," says the study's lead author Antonis Kourtidis, Ph.D., a research associate in Dr. Anastasiadis' lab. "Most significantly, it uncovers a new strategy for cancer therapy," he adds.
That problem arose from conflicting reports about E-cadherin and p120 catenin -- adhesion proteins that are essential for normal epithelial tissues to form, and which have long been considered to be tumor suppressors. "However, we and other researchers had found that this hypothesis didn't seem to be true, since both E-cadherin and p120 are still present in tumor cells and required for their progression," Dr. Anastasiadis says. "That led us to believe that these molecules have two faces -- a good one, maintaining the normal behavior of the cells, and a bad one that drives tumorigenesis."
Their theory turned out to be true, but what was regulating this behavior was still unknown. To answer this, the researchers studied a new protein called PLEKHA7, which associates with E-cadherin and p120 only at the top, or the "apical" part of normal polarized epithelial cells. The investigators discovered that PLEKHA7 maintains the normal state of the cells, via a set of miRNAs, by tethering the microprocessor to E-cadherin and p120. In this state, E-cadherin and p120 exert their good tumor suppressor sides.
However, "when this apical adhesion complex was disrupted after loss of PLEKHA7, this set of miRNAs was misregulated, and the E-cadherin and p120 switched sides to become oncogenic," Dr. Anastasiadis says.
"We believe that loss of the apical PLEKHA7-microprocessor complex is an early and somewhat universal event in cancer," he adds. "In the vast majority of human tumor samples we examined, this apical structure is absent, although E-cadherin and p120 are still present. This produces the equivalent of a speeding car that has a lot of gas (the bad p120) and no brakes (the PLEKHA7-microprocessor complex).
"By administering the affected miRNAs in cancer cells to restore their normal levels, we should be able to re-establish the brakes and restore normal cell function," Dr. Anastasiadis says. "Initial experiments in some aggressive types of cancer are indeed very promising."
INFORMATION:
Co-authors include Siu Ngok, Ph.D.; Ryan Feathers; Lomeli Carpio; Tiffany Baker; Jennifer Carr; Irene Yan; Sahra Borges, Ph.D.; Edith Perez, M.D.; Peter Storz, Ph.D.; John Copland, Ph.D.; Tushar Patel, M.B., Ch.B.; and E. Aubrey Thompson, Ph.D., from Mayo Clinic; and Pamela Pulimeno, Ph.D., and Sandra Citi, M.D., Ph.D., from the University of Geneva in Switzerland.
The study was supported by the National Institutes of Health grants R01 CA100467, R01 NS069753, P50 CA116201, R01 GM086435, R01CA104505, R01CA136665; the Florida Department of Health, Bankhead-Coley grants 10BG11; the Breast Cancer Research Foundation; the Swiss Cancer League; and the Jay and Deanie Stein Career Development Award for Cancer Research at Mayo Clinic.
About Mayo Clinic
Mayo Clinic is a nonprofit organization committed to medical research and education, and providing expert, whole-person care to everyone who needs healing. For more information, visit mayoclinic.com or newsnetwork.mayoclinic.org.
MULTIMEDIA ALERT: Video and audio are available for download on the Mayo Clinic News Network. END
Women accounted for the majority of graduate medical education (GME) trainees in seven specialties in 2012 but in no specialties were the percentages of black or Hispanic trainees comparable with the representation of these groups in the U.S. population, according to a research letter published online by JAMA Internal Medicine.
Diversifying the physician workforce in the United States is an ongoing goal.
Curtiland Deville, M.D., of Johns Hopkins University, Baltimore, and coauthors used publicly reported data to assess the representation of women and historically underrepresented ...
The use of statins for primary prevention in patients without vascular disease older than 79 increased between 1999 and 2012, although there is little randomized evidence to guide the use of these cholesterol-lowering medications in this patient population, according to a research letter published online by JAMA Internal Medicine.
Michael E. Johansen, M.D., M.S., of Ohio State University, Columbus, and Lee A. Green, M.D., M.P.H., of the University of Alberta, Canada, investigated the use of statins among this population by vascular disease because the very elderly have ...
Discontinuing antihypertensive therapy for patients 75 or older with mild cognitive deficits did not improve short-term cognitive, psychological or general daily functioning, according to an article published online by JAMA Internal Medicine.
Midlife high blood pressure is a risk factor for cerebrovascular disease. However, the effect of late-life blood pressure on cognition is less clear. Some studies have suggested that late in life, it is lower, rather than higher blood pressure, that increases the risk for cognitive decline.
Justine E. F. Moonen, M.D., of Leiden ...
A study matching newborn glucose concentration screening results with fourth-grade achievement test scores suggests that early transient newborn hypoglycemia (low blood sugar) was associated with lower test scores at age 10, according to an article published online by JAMA Pediatrics.
At birth, the continuous utero-placental-umbilical infusion of glucose ends and reaches the lowest values during the first couple of hours. The newborn brain principally uses glucose for energy and prolonged hypoglycemia has been associated with poor long-term neurodevelopment and neurocognition. ...
TORONTO, ON - A team of physicists at the University of Toronto (U of T) have taken a step toward making the essential building block of quantum computers out of pure light. Their advance, described in a paper published this week in Nature Physics, has to do with a specific part of computer circuitry known as a "logic gate."
Logic gates perform operations on input data to create new outputs. In classical computers, logic gates take the form of diodes or transistors. But quantum computer components are made from individual atoms and subatomic particles. Information processing ...
Researchers at NYU Langone Medical Center have found how even brief exposure to sudden sounds or mild trauma can form permanent, long-term brain connections, or memories, in a specific region of the brain. Moreover, the research team, working with rats, says it was able to chemically stimulate those biological pathways in the locus coeruleus -- the area of the brain best known for releasing the "fight or flight" hormone noradrenaline -- to heighten and improve the animals' hearing.
The NYU team says their new study, summarized in the cover article in the journal Nature ...
This news release is available in German.
An international team of scientists led by the University of Bayreuth and with participation of DESY has created the highest static pressure ever achieved in a lab: Using a special high pressure device, the researchers investigated the behaviour of the metal osmium at pressures of up to 770 Gigapascals (GPa) - more than twice the pressure in the inner core of the Earth, and about 130 Gigapascals higher than the previous world record set by members of the same team. Surprisingly, osmium does not change its crystal structure ...
BOSTON -- In response to the growing opioid crisis, several states, including Massachusetts and Rhode Island, have granted pharmacists the authority to provide naloxone rescue kits without a prescription to at-risk patients. This model of pharmacy-based naloxone (PBN) education and distribution is one of the public health strategies currently being evaluated at hundreds of pharmacies in both states to determine the impact on opioid overdose death rates.
Led by researchers at Boston Medical Center (BMC), Rhode Island Hospital, and the University of Rhode Island College ...
For software programmers, security tools are analytic software that can scan or run their code to expose vulnerabilities long before the software goes to market. But these tools can have shortcomings, and programmers don't always use them. New research from National Science Foundation-funded computer science researcher Emerson Murphy-Hill and his colleagues tackles three different aspects of the issue.
"Our work is focused on understanding the developers who are trying to identify security vulnerabilities in their code, and how they use (or don't use) tools that can help ...
URBANA, Ill. - Men and persons age 65 and older who have access to natural surroundings, whether it's the green space of a nearby park or a sandy beach and an ocean view, report sleeping better, according to a new University of Illinois study published in Preventive Medicine.
"It's hard to overestimate the importance of high-quality sleep," said Diana Grigsby-Toussaint, a U of I professor of kinesiology and community health and a faculty member in the U of I's Division of Nutritional Sciences. "Studies show that inadequate sleep is associated with declines in mental ...
